View details of this raise on Seedstage

Oakland, CA

Developing cultivated bluefin tuna to meet global seafood demand sustainably.

• Tier-1 Venture Backing: The company is supported by leading venture capital firms.
• Sustainable Seafood Solution: Offers a cultivated alternative to overfishing and aquaculture.
• FDA Review Underway: Engaged with the FDA for regulatory approval of sashimi-grade tuna.
• Adaptable Technology: Patent-pending technology applicable to the $360B+ seafood market.
• Expansion Opportunities: Exploring markets in protein, collagen, and functional foods.

Finless Foods is addressing the critical supply-and-demand issues faced by the Pacific Bluefin Tuna, a fish highly prized in sushi cuisine. The company is developing a sustainable alternative to traditional fishing and aquaculture by producing cultivated bluefin tuna. This method eliminates concerns related to mercury, microplastics, and environmental harm associated with overfishing and aquaculture. Finless Foods’ technology is adaptable, allowing for expansion into the broader seafood market, which is valued at over $360 billion.

The company is also exploring opportunities in the protein, collagen, and functional foods markets, leveraging its proprietary cell line technology. Finless Foods is currently undergoing FDA review for its sashimi-grade tuna product, with approval expected to open doors for commercialization and expansion into international markets. The company has established partnerships with major food distributors and is working with Cultivate at Scale to refine its production process. With backing from tier-1 venture capital firms and a leadership team with deep biotechnology expertise, Finless Foods is poised to make a significant impact in the sustainable seafood industry.

Company Info

Finless Foods develops cultivated bluefin tuna to meet seafood demand sustainably, free from environmental harm.

Finless Foods is focused on producing sustainable, sushi-grade bluefin tuna through cell cultivation technology. This approach aims to address the growing demand for high-quality seafood without the environmental impact associated with traditional fishing and aquaculture. By developing a proprietary cell line of Pacific Bluefin Tuna, Finless Foods offers a clean and versatile protein option free from mercury and microplastics. Their technology is adaptable, allowing for potential expansion into the broader seafood market and other high-value marine species.

The company is working towards FDA approval for its sashimi-grade tuna product, which is expected to be a significant milestone for commercialization. Finless Foods is also exploring opportunities in the functional foods and supplement markets, leveraging the nutritional benefits of tuna protein and collagen. With established relationships with major food distributors and ongoing collaborations to refine their production process, Finless Foods is positioning itself for scalable production and distribution.